NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/27/2021
Back to search
Official data from USPTO
CELLCHAIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
CELLCHAIN
ST13
US500000079270693Class
35, 42
Filing
79270693
Registration
6015966
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
10/27/2021
Classification
Registered
Trademark type
Word
Nice classes
35, 42
Filing date
09/04/2019
Registration date
03/24/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2020
Last transaction
03/24/2020
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
25
Owner location
CH
Examiner
CASTRO, GIANCARLO
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NOVARTIS AG
Representatives
Novartis Pharma AG, Trademark Department
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Computerized on-line ordering services in the field of personalized cell therapy
Class 42
Providing temporary use of on-line non-downloadable software for placingverifyingtrackingmonitoring and fulfilling orders for therapeutic treatments in the field of personalized cell therapy
Publications
History of USPTO decisions and trademark events.
16 publications found
GPNX
NOTIFICATION PROCESSED BY IB
05/22/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/07/2020
FIMP
FINAL DISPOSITION PROCESSED
05/07/2020
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
04/23/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2020
PUBO
PUBLISHED FOR OPPOSITION
01/07/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/04/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/18/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/18/2019
NPUB
NOTICE OF PUBLICATION
12/18/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2019
DOCK
ASSIGNED TO EXAMINER
11/26/2019
MAFR
APPLICATION FILING RECEIPT MAILED
11/12/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/06/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/31/2019
Continuous trademark protection
Get notified about every new filing that threatens CELLCHAIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.